Norswertianin is a xanthone compound that functions as a potent anti-glioma agent. It induces differentiation in glioblastoma (GBM) cells through oxidative stress and autophagy, mechanisms dependent on the inhibition of the Akt/mTOR signaling pathway. This small molecule is utilized in neuroscience and oncology research for in vitro studies targeting glioma cell proliferation and differentiation.